MedPath

National Plaque Registry and Database

Not yet recruiting
Conditions
Atherosclerosis
Coronary Artery Disease
Cardiovascular Disease
Registration Number
NCT02578355
Lead Sponsor
Semmelweis University Heart and Vascular Center
Brief Summary

The ultimate goal of this project is to develop a risk score to identify patients with vulnerable coronary atherosclerotic plaques, who are prone to suffer acute coronary syndrome. Early identification of vulnerable plaques may have an enormous impact on public health through primary and secondary prevention of acute myocardial infarction.

Investigators hypothesize that a risk score that incorporates non-invasive coronary CT imaging (calcium score and/or coronary CTA) in combination with clinical characteristics (classical risk prediction models) will improve the identification of patients who are at highest risk to suffer myocardial infarction or sudden cardiac death.

The overall goal of the OPeRA project is to develop, implement and validate a novel risk assessment tool based on image markers and clinical characteristics to identify patients who are at increased risk to suffer myocardial infarction or sudden cardiac death.

Detailed Description

The primary goals of OPeRA consortium:

To develop a national coronary CTA registry with the collaboration of all major cardiac CT centers of Hungary (Országos Plaque Regiszter és Adatbázis - NatiOnal Plaque Registry and DAtabase, OPeRA).

1. To develop a novel risk assessment tool (OPeRA score) based on image markers and clinical characteristics.

2. To identify and validate novel vulnerable coronary plaque image markers and assess their prognostic value.

Secondary goals:

1. To develop a standardized and structured, national coronary CTA reporting system.

2. To establish a national quality control system that monitors the quantity of iodinated contrast agent and the patients' radiation dose.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
20000
Inclusion Criteria
  • Age > 18 years
  • Subject providing written informed consent
  • Scheduled to undergo a clinically indicated coronary CTA
Exclusion Criteria
  • Age <18 years
  • Suspicion of acute coronary syndrome (acute myocardial infarction and unstable angina)
  • Recent prior myocardial infarction within 30 days prior to coronary CTA or between coronary CTA and ICA
  • Pregnancy or unknown pregnancy status in subject of childbearing potential
  • Subject requires an emergent procedure
  • Evidence of ongoing or active clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure with systolic blood pressure <90 mmHg, and severe congestive heart failure (NYHA III or IV) or acute pulmonary edema
  • Inability to comply with study procedures

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All cause death10 years
Secondary Outcome Measures
NameTimeMethod
Myocardial infarction10 years
Target vessel revascularization10 years
CAD-related hospitalization10 years
Unstable angina10 years

Trial Locations

Locations (11)

University of Szeged

🇭🇺

Szeged, Csongrád, Hungary

Petz Aladár County Teaching Hospital

🇭🇺

Győr, Győr-Moson-Sopron, Hungary

University of Pécs

🇭🇺

Pécs, Baranya, Hungary

Pozitron Diagnostic Center

🇭🇺

Budapest, Hungary

Markhot Ferenc Teaching Hospital and Clinic

🇭🇺

Eger, Heves, Hungary

Borsod-Abaúj-Zemplén County Hospital and Teaching Hospital

🇭🇺

Miskolc, Borsod-Abaúj-Zenpén, Hungary

Pándy Kálmán County Hospital

🇭🇺

Gyula, Békés, Hungary

Homeland Defence Hospital

🇭🇺

Budapest, Pest, Hungary

Health Centrum, Kaposvár University

🇭🇺

Kaposvár, Somogy, Hungary

Markusovszky Teaching Hospital

🇭🇺

Szombathely, Vas, Hungary

University of Debrecen

🇭🇺

Debrecen, Hajdú-Bihar, Hungary

© Copyright 2025. All Rights Reserved by MedPath